Similar articles

• Lipid disorders.

  Kole LA. Kole LA. JAAPA. 2009 Nov;22(11):54-5. doi: 10.1097/01720610-200911000-00016. JAAPA. 2009. PMID: 19999177 No abstract available.
• Cardiovascular primary prevention: how high should we set the bar?

  Prasad V, Vandross A. Prasad V, et al. Arch Intern Med. 2012 Apr 23;172(8):656-9; discussion 659. doi: 10.1001/archinternmed.2012.812. Arch Intern Med. 2012. PMID: 22529231
• Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk.

  Brown BG, Zhao XQ. Brown BG, et al. Am J Cardiol. 2008 Apr 17;101(8A):58B-62B. doi: 10.1016/j.amjcard.2008.02.039. Am J Cardiol. 2008. PMID: 18375243 Review.
• [Raising HDL cholesterol: which is the best strategy?].

  Alfonso JE, Ariza ID. Alfonso JE, et al. Rev Assoc Med Bras (1992). 2008 Jul-Aug;54(4):369-76. doi: 10.1590/s0104-42302008000400025. Rev Assoc Med Bras (1992). 2008. PMID: 18719798 Review. Spanish.
• Drugs for lipids.

  [No authors listed] [No authors listed] Treat Guidel Med Lett. 2008 Feb;6(66):9-16. Treat Guidel Med Lett. 2008. PMID: 18216759 Review. No abstract available.